PROM1 and hepatocellular carcinoma: Purified CD133+ cells, isolated from a human hepatocellular carcinoma (HCC) cell line and mouse xenografts were found to be more resistant to the chemotherapeutic drugs doxorubicin and fluoruracil compared to cells lacking the CD133 phenotype.